Product NDC: | 0615-7692 |
Proprietary Name: | Metolazone |
Non Proprietary Name: | metolazone |
Active Ingredient(s): | 5 mg/1 & nbsp; metolazone |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0615-7692 |
Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076698 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100118 |
Package NDC: | 0615-7692-39 |
Package Description: | 30 TABLET in 1 BLISTER PACK (0615-7692-39) |
NDC Code | 0615-7692-39 |
Proprietary Name | Metolazone |
Package Description | 30 TABLET in 1 BLISTER PACK (0615-7692-39) |
Product NDC | 0615-7692 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | metolazone |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20100118 |
Marketing Category Name | ANDA |
Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
Substance Name | METOLAZONE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Increased Diuresis [PE],Thiazide-like Diuretic [EPC] |